Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websiteandrobiosys.com
CategoryBioTech
Phone716-849-6810
Employees
Description Cancer and Prostate Treatment Research

Offices

New York, USA
73 High St. Buffalo, NY 14203
New York, NY, 14203
USA

People

Funding

Tags

AndroBioSys

AndroBioSys, Inc. (ABS), is a biotechnology company dedicated to the development of novel treatments for prostate disease. Based on technologies developed at Roswell Park Cancer Institute, AndroBioSys is pioneering new approaches to make treatment of prostate cancer curative, not palliative. Preventing progression of prostate disease is intertwined intimately with disruption of the androgen axis. ABS performs contract research screening services for academic, biotechnology and pharmaceutical clients and develops collaborative partnerships to discover new drugs to proprietary prostate disease targets.

Recent Milestones

Videos

Screenshots

AndroBioSys screenshot
Above: AndroBioSys Screenshot -- #1
Uploaded: 6/23/09

Sources

  1. AndrosBioSys Inc. secures $500K (buffalo.bizjournals.com) [edit]
Edit This Page
Last Edited 8/21/12

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy